A prospective study was (5, 10, 12) . The test has since become a preferred method for definitive serodiagnosis of VZV infection. More recently, the enzyme-linked immunosorbent assay (ELISA) has also been shown to be equal to or better than such standard assays as complement fixation, neutralization, and immune adherence hemagglutination for detecting IgG antibodies to VZV (3). The FAMA test and the ELISA have been directly compared in only one previous study, by Shanley et al. (8). In that study, the FAMA test and the ELISA were comparable in specificity but not in sensitivity. For reasons related to cost, ease and rapidity of performance, and broader t Deceased. utilization, it is desirable for equivalent tests for serodiagnosis of VZV infection to be defined.
The results indicated that the ELISA and the FAMA test have similar capacities to define susceptibility to varicella-zoster virus and that subclinical infection with varicella-zoster virus may be common.
The fluorescent antibody to membrane antigen (FAMA) assay for detecting immunoglobulin G (IgG) antibody to varicella-zoster virus (VZV) was first described by Williams et al. (11) in 1974. It soon became apparent that the FAMA was a notable advance in the serodiagnosis of VZV infections since it reliably differentiated susceptible and immune individuals and was specific even at very low serum dilutions (5, 10, 12) . The test has since become a preferred method for definitive serodiagnosis of VZV infection. More recently, the enzyme-linked immunosorbent assay (ELISA) has also been shown to be equal to or better than such standard assays as complement fixation, neutralization, and immune adherence hemagglutination for detecting IgG antibodies to VZV (3) . The FAMA test and the ELISA have been directly compared in only one previous study, by Shanley et al. (8) . In that study, the FAMA test and the ELISA were comparable in specificity but not in sensitivity. For reasons related to cost, ease and rapidity of performance, and broader t Deceased. utilization, it is desirable for equivalent tests for serodiagnosis of VZV infection to be defined.
In comparison with most cell types, human diploid embryo fibroblasts (HDEF) are highly susceptible to VZV infection and are the cell type most often used in FAMA tests. LevontonKriss and co-workers (7) FAMA test. The FAMA assay was carried out by the procedure of Zaia and Oxman (13) ELISA. The microtiter plate procedure of Voller et al. (9) was used with modifications. Polystyrene microtiter plates (Dynatech Laboratories, Inc., Alexandria, Va.) were coated overnight at 4°C with VZV antigen diluted in bicarbonate-carbonate buffer (pH 9.6). For antigen preparation, VZV-infected HDEF cells were harvested by scraping when they displayed 4+ cytopathic effects. Cells were washed three times in 0.1 M Tris-buffered saline (MA Bioproducts), and after the final wash the pellet was suspended to 0.5 ml of Tris-buffered saline per 150-cm2 flask and sonicated. The lysate was centrifuged at 3,000 rpm for 15 min, and the supernatant was used as VZV antigen. Uninfected HDEF antigen was prepared in a like manner, and the protein concentration was determined and used in a concentration equivalent to that of VZV antigen. The ELISA procedure with goat anti-human IgG alkaline phosphatase conjugate (MA Bioproducts) was carried out as previously described (2 Representative ELISA titration curves showing the reaction of antigen with increasing serum dilutions are shown in Fig. 1 . A prozone-like effect was frequently but not invariably observed with sera titrated by ELISA. This was evident from the fact that absorbance increased with greater serum dilution before it decreased steadily with further serum dilution. There was no correlation of this observation with serum titer or with whether the infection had been recent or remote. The reason for this prozonelike phenomenon is not clear. Table 1 summarizes the results of FAMA and ELISA tests to detect IgG antibody to VZV in the 75 sera from members of the 10 families. The geometric mean titer obtained by ELISA (mean ± standard deviation, 235.57 ± 11.88) was significantly higher than that obtained by FAMA testing (14.22 ± 6.23). However, the sensitivity in terms of the percentage of sera positive for antibodies was similar, although the ELISA consistently gave higher endpoint titers (Fig. 2) . The results differed with only two serum samples, IAl and IIIAL. Since these sera were obtained 1 or 2 days after the appearance of vesicular rash, the results were consistent with the detection of low levels of developing antibodies by one or the other test but not by both. These times of appearance of VZV-specific IgG were earlier than those reported in previous studies, where IgG was not detected until 5 days after the onset of rash (1, 4) .
One or more serum specimens from 8 of 10 index cases were tested, and antibodies were detected by both the FAMA test and the ELISA in at least one specimen in all cases. Paired acute-and convalescent-phase sera were obtained in two index cases (IA and IVA), and 12 
